Picotine de Capucin.
Natural health product licensed in Canada
- Licence holder
- Capucin & Cie Inc.
- NPN or DIN-HM
- 80007408
- Status
- Active licence
- Licence date
- 4 September 2008
- Revision date
- 7 January 2019
- Form
- Gouttes
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Antimonium crudum Source : Antimonium crudum | 6 CH | Not calculated |
| Croton tiglium Source : Huile de graines | 5 CH | Not calculated |
| Rhus toxicodendron Source : Feuille(s) | 7 CH | Not calculated |
| Arsenicum album Source : Arsenicum album | 9 CH | Not calculated |
Non-medicinal ingredients
Alcool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Nourrissons | maximum: 11 months | Not specified | Not specified |
| Enfants | minimum: 6 years ; maximum: 11 years | Not specified | Not specified |
| Enfants | minimum: 1 year ; maximum: 5 years | Not specified | Not specified |
Uses authorised in Canada
Remède homéopathique qui soulage efficacement les symptômes de la varicelle tels que; la démangeaison et la sensation de brûlure provoquée par les lésions ulcérées de la peau et des muqueuses.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas dépasser la dose recommandée. Consulter un praticien en soins de santé: En cas de fièvre, de nouveaux symptômes ou de symptômes qui s'aggravent pendant plus de 48 heures. Cessez l'utilisation si les symptômes persistent ou ne s'améliorent pas dans les 7 jours suivants la prise de ce médicament homéopathique.
Source
Official Health Canada record, licence 80007408
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging